CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) Form S-1/A — Jun 26, 2026
Creative Medical Technology Holdings filed an amendment to its registration statement for a best efforts public offering of up to 3,045,685 shares of common stock and accompanying warrants. The company set an assumed combined public offering price of $1.97 per share and warrants, aiming to raise estimated net proceeds of approximately $5.34 million. Proceeds from the offering are intended to fund Phase I/II clinical trials for chronic lower back pain and Type 1 Diabetes, continue the IPScelz program with Greenstone Biosciences, and support working capital.
Key figures
- Cash Position
- 5723176
- Offering Price
- 1.97
- Shares Offered
- 3045685
- Dilution Per Share
- $0.37
- Placement Agent Fee
- 8.0%
- Net Proceeds Estimate
- $5,340,000
- Public Warrants Offered
- 6,091,371
- Warrants Exercise Price
- Immediately exercisable, 5 year term
Price after filing
Close on the filing date to close N calendar days later (from $2.00). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.